JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors
Release Date:
Tom Marwick, MBBS, PhD, MPH and Sivatharshini Ramalingam, MD discuss discuss the study design and findings, as well as the future use and potential development of cardio-oncology specific risk scores for prediction of heart failure in cancer survivors.
JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors